Liu Sixi, director of the Department of Hematology and Oncology of Shenzhen Children's Hospital, and his team visited Shenzhen Cell Valley
At the symposium, Professor Shi Yuanyuan, chairman of the board, warmly welcomed the arrival of Director Liu Sixi's team and introduced in detail the technical advantages and innovative achievements of Cell Valley in the field of cell therapy. As a major project in Shenzhen and a major public service platform for the biomedical industry, Shenzhen Cell Valley focuses on one-stop comprehensive services in the field of cell and gene therapy, with profound technical accumulation and international vision. Professor Shi Yuanyuan said that the clinical grade cell products prepared by Shenzhen Cell Valley based on retrovirus vectors have the advantages of high safety, low cost, high infection efficiency and stability, and good in vivo expansion effect. These products provide a high-quality and inexpensive cell therapy option for patients with advanced hematologic tumors, and provide a promising exploration for the large-scale and industrial application of cell therapy products.
Under the leadership of Director Liu Sixi, the Department of Hematology and Oncology of Shenzhen Children's Hospital is the leading pediatric blood tumor diagnosis and treatment team in China, with rich clinical experience in hematopoietic stem cell transplantation and precision treatment of pediatric blood tumors. Director Liu Sixi's team highly recognized the technical strength and scientific research achievements of Shenzhen Cell Valley in the field of cell therapy, and hoped to further promote the clinical research and therapeutic application of children's blood tumors with the help of Cell Valley's technical advantages and rich clinical cooperation experience in the field of cell therapy.
This visit has laid a solid foundation for the cooperation between Shenzhen Cell Valley and Shenzhen Children's Hospital, and the two sides will work together to promote innovative development in the field of pediatric blood tumor treatment and bring hope to more patients.
